202 related articles for article (PubMed ID: 24147470)
1. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer.
Sandrasegaran K; Nutakki K; Tahir B; Dhanabal A; Tann M; Cote GA
AJR Am J Roentgenol; 2013 Nov; 201(5):1002-8. PubMed ID: 24147470
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI: usefulness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas.
Kang BK; Kim JH; Byun JH; Lee SS; Kim HJ; Kim SY; Lee MG
Acta Radiol; 2014 Dec; 55(10):1157-65. PubMed ID: 24259300
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Hata T; Kurata M; Honda G; Tsuruta K; Suzuki M; Kamata N; Sasaki T
Am J Gastroenterol; 2010 Aug; 105(8):1870-5. PubMed ID: 20216538
[TBL] [Abstract][Full Text] [Related]
5. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
6. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
Kang KM; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.
Lee SS; Byun JH; Park BJ; Park SH; Kim N; Park B; Kim JK; Lee MG
J Magn Reson Imaging; 2008 Oct; 28(4):928-36. PubMed ID: 18821618
[TBL] [Abstract][Full Text] [Related]
8. High-b-value diffusion-weighted magnetic resonance imaging of pancreatic cancer and mass-forming chronic pancreatitis: preliminary results.
Takeuchi M; Matsuzaki K; Kubo H; Nishitani H
Acta Radiol; 2008 May; 49(4):383-6. PubMed ID: 18415779
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas.
Fattahi R; Balci NC; Perman WH; Hsueh EC; Alkaade S; Havlioglu N; Burton FR
J Magn Reson Imaging; 2009 Feb; 29(2):350-6. PubMed ID: 19161187
[TBL] [Abstract][Full Text] [Related]
10. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
11. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.
Kang TW; Kim SH; Park HJ; Lim S; Jang KM; Choi D; Lee SJ
Clin Radiol; 2013 Oct; 68(10):992-1001. PubMed ID: 23622795
[TBL] [Abstract][Full Text] [Related]
12. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
Wang CL; Chea YW; Boll DT; Samei E; Neville AM; Dale BM; Merkle EM
Eur J Radiol; 2011 Nov; 80(2):e1-7. PubMed ID: 20646887
[TBL] [Abstract][Full Text] [Related]
13. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
14. DWI findings of autoimmune pancreatitis: comparison between symptomatic and asymptomatic patients.
Oki H; Hayashida Y; Oki H; Kakeda S; Aoki T; Taguchi M; Harada M; Korogi Y
J Magn Reson Imaging; 2015 Jan; 41(1):125-31. PubMed ID: 24273124
[TBL] [Abstract][Full Text] [Related]
15. Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level.
Park MJ; Kim YK; Choi SY; Rhim H; Lee WJ; Choi D
Radiology; 2014 Nov; 273(2):433-43. PubMed ID: 24991989
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging.
Huang WC; Sheng J; Chen SY; Lu JP
J Dig Dis; 2011 Oct; 12(5):401-8. PubMed ID: 21955434
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.
Sandrasegaran K; Tahir B; Nutakki K; Akisik FM; Bodanapally U; Tann M; Chalasani N
AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359
[TBL] [Abstract][Full Text] [Related]
18. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.
Jang KM; Kim SH; Lee SJ; Choi D
Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
20. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
